CDKN1A and central nervous system neoplasm: Among CNS tumors, gains and losses were distributed throughout the genome with some chromosome arms having a higher rate of either gain (7q, 8q, 12q) or loss (9p, specifically CDKN1A and CDKN2B) (Fig. 1).